
Neon Therapeutics
Focused on unlocking the full potential of the immune system to recognize and attack cancer.
Employees
Enterprise value
$67m
Get premium to view all results
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor | €0.0 | round |
investor investor investor | €0.0 | round | |
investor | €0.0 | round | |
investor investor investor investor investor investor investor | €0.0 Valuation: €0.0 | round | |
N/A | €0.0 Valuation: €0.0 | round | |
$67.0m Valuation: $67.0m | Acquisition | ||
Total Funding | 000k |

Access Industries(exited)

Hillhouse Capital(exited)

ArrowMark Partners(exited)

Casdin Capital(exited)

Nextech Venture(exited)

Wellington Management(exited)

Fidelity Investments(exited)

Third Rock Ventures(exited)

Clal Biotechnology Industries(exited)

Nextech Invest(exited)

Inbio Ventures(exited)

PFM Health Sciences(exited)
USD | 2018 | 2019 | 2020 |
---|---|---|---|
Revenues | 0000 | 0000 | 0000 |
EBITDA | 0000 | 0000 | 0000 |
% EBITDA margin | - | - | (600 %) |
Profit | 0000 | 0000 | 0000 |
% profit margin | - | - | (670 %) |
EV | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.